Funding profile · Fertility & family planning

Lilia

Two press-reported rounds totaling $2.2 million by 2020, a founder who later cited a lower total, an aggregator that cites a higher one, and no SEC Form D under any name tried here. Here is what the record shows, and where it does not agree with itself.

$800KPre-seed, raised in about five weeks (Aug 2019)
$1.4MSeed round, reported Apr 2020
$2.35MCumulative total, PitchBook (accessed Jul 2026)
0Form D filings found under Lilia, Inc. in SEC EDGAR

Data as of September 25, 2026. Company-reported figures are labeled.

Rounds at a glance

When Round Amount Investors Source
Aug 2019 Pre-seed $800,000, against an initial $250,000 goal Hustle Fund, Panache Ventures, Michele Romanow (Clearbanc), Ramen Ventures, Huda Idrees (Dot Health) Independent
Mar 2020 Accelerator, Y Combinator Winter 2020 Not disclosed Y Combinator PitchBook
Apr 2020 Seed $1,400,000 Y Combinator, Garage Capital, Panache Ventures, Hustle Fund Independent
Feb 2022 Secondary transaction, private Not disclosed Not named PitchBook
By Jul 2022 Cumulative, as told to Forbes “roughly $1.5 million” Not itemized Company-stated
As of Jul 2026 Cumulative, PitchBook total $2,350,000 14 investors; 5 named, including Adventure Capital (Canada), Bogaroo, Garage Capital, Icebook Investments, Roach Capital PitchBook

What the filings show

No SEC Form D was found for Lilia. A full text search of SEC EDGAR for “Lilia, Inc.,” “hellolilia,” and “Alyssa Atkins” returned no results as of September 25, 2026. The one entity that does surface under the name Lilia, a 2026 Form D from “LILIA AI, INC.,” lists a Houston, Texas address and a different EIN, and is not this company. Two things are consistent with the absence of a filing: Lilia started as a Toronto, Ontario company, and pre-seed and seed rounds this size can also be raised privately under Section 4(a)(2) without triggering a Regulation D notice, or through a Canadian entity that never files with the SEC at all. Either way, the two rounds documented here come from press reporting and a data aggregator, not from a primary securities filing.

Reading the record

  1. The pre-seed beat its own target by more than 3 times.Atkins set out to raise $250,000 and closed $800,000 in about five weeks, according to The Globe and Mail, a detail PitchBook’s deal history corroborates with the same date and amount.
  2. The two reported rounds alone outrun the company’s later self-reported total.$800,000 in 2019 plus $1.4 million in 2020 comes to $2.2 million, yet Atkins told Forbes in July 2022 that Lilia had raised “roughly $1.5 million to date.” That is about $700,000 short of the sum of the two rounds the press had already reported two years earlier, and the gap is not explained anywhere in the record found here.
  3. PitchBook’s cumulative figure runs the other direction.Its $2.35 million total is higher than both the sum of the two named rounds and the company’s own 2022 figure. Part of that gap may be the February 2022 secondary transaction PitchBook lists, which moves existing shares between holders rather than raising new capital, so it should not necessarily be counted toward a “raised” total the way a primary round is.
  4. The named capital table skews Canadian and early stage.Of PitchBook’s 14 listed investors, the 5 named are Adventure Capital (Canada), Bogaroo, Icebook Investments, Roach Capital, and Garage Capital, alongside the Globe and Mail’s list of Hustle Fund, Panache Ventures, Ramen Ventures, Clearbanc’s Michele Romanow, and Dot Health’s Huda Idrees. These read as pre-seed and seed-stage angels and small funds, not the larger health-focused growth investors that later-stage fertility startups typically attract.
  5. Headquarters address is itself a discrepancy.PitchBook lists a Toronto, Ontario corporate office; Y Combinator’s own company page lists San Francisco. Both can be true at different points, since the company started in Toronto and later built its clinical network around New York, Chicago, and San Francisco, but no source found here pins down exactly when, or whether, the headquarters formally moved.
  6. Status disagrees across sources.Y Combinator marks Lilia “Inactive.” PitchBook, in a page dated July 31, 2026, still lists it as “Private” with the deal stage “Generating Revenue.” The founder’s own account, of stepping back because reaching venture scale would require operating clinics directly, and of an acquisition offer that fell through over a visa issue, is consistent with Y Combinator’s tag, not PitchBook’s.

Commercial signals

Signal Detail Source type
Pricing Flat fee model: $9,000 all in as of Jul 2022; by 2024, $9,500 in San Francisco, Los Angeles and Chicago, $10,500 in New York City, storage $840 a year. Company-stated
Revenue “$0 to $850,000 in revenue” without paid ads, per the founder’s own site. No independent revenue figure found. Company-stated
Clinic network Partnerships described with NYU, Columbia, and Kindbody; medical leadership credited to Dr. Roohi Jeelani as of 2022. Company-stated
Expansion plan Operating in New York, Chicago, and San Francisco by mid 2022, with a stated plan to go national by end of 2023. No later city announcements found. Company-stated
Founder transition Atkins describes stepping back from Lilia to become Head of Marketing at Limitless (formerly Rewind), after an acquisition offer from an unnamed “industry incumbent” fell through over a visa issue. Company-stated

What to watch

  • Whether Crunchbase or PitchBook ever update Lilia’s status to match Y Combinator’s “Inactive” tag.
  • Any SEC filing, under Lilia, Alyssa Atkins, or a successor entity, that would settle the gap between the company’s $1.5 million figure and the $2.2 million to $2.35 million shown by press reports and PitchBook.
  • Whether hellolilia.com, still a live site as of September 25, 2026, keeps operating or is simply left online.
  • Confirmation of the acquisition talks Atkins described, including who the buyer was.

The Lilia story on Healthcare DiscoveryHealthcare Discovery

Related companies

  • Avro Life Science: Shared investor: Garage Capital. Two University of Waterloo first years set out to put a generic allergy pill into a sticker
  • LunaBill: Shared investor: Garage Capital. AI voice agents that call insurance companies on a hospital's behalf, chasing unpaid claims the way a biller would, around the clock
  • Modern Fertility: Also in Consumer Health and Wellness. A finger prick hormone panel sold to women who were not trying to conceive
  • Inito: Also in Consumer Health and Wellness. A smartphone connected urine test that reports four reproductive hormones as numbers instead of lines

Sources

  1. IndependentToronto fertility startup Lilia attracts early interest from investorsThe Globe and Mail, Stefanie Marotta · Aug 18, 2019
  2. IndependentFemBeat: YC-Backed Lilia Raises A $1.4 Million Seed Round To Help Women Navigate And Celebrate Egg FreezingForbes, Bérénice Magistretti · Apr 23, 2020
  3. IndependentY Combinator-Backed Lilia Launches A More Convenient And Affordable Egg Freezing Offering Built For The Millennial WomenForbes, Marija Butkovic · Jul 14, 2022
  4. IndependentOn Your Time: The Startups Making Egg Freezing More AccessibleSara Friedman · Apr 5, 2024
  5. IndependentLilia company profile: valuation, funding and investorsPitchBook · accessed Jul 31, 2026
  6. IndependentLilia company profileY Combinator · accessed Sep 25, 2026
  7. CompanyPersonal site and founder bio, “Things I’m proud of” and “Lilia, founding a YC company”alyssaatkins.co · accessed Sep 25, 2026
  8. Not foundFull text search for “Lilia, Inc.,” “hellolilia,” and “Alyssa Atkins”: no matching filingsSEC EDGAR · Sep 25, 2026
  9. Public recordCompany submissions for CIK 0002111903, LILIA AI, INC., Houston, Texas: a distinct, unrelated entitySEC EDGAR · Sep 25, 2026

Compiled from SEC records, press reports, and PitchBook data as of September 25, 2026. No SEC Form D was located for this company under the names tried here; amounts described as company-reported reflect what the founder has stated publicly and are not independently verified. Healthcare Venture Capital Fund holds no position in Lilia. This page is not an offer to sell or a recommendation to buy any security.